Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
LeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Sagimet Biosciences (SGMT) Shares Issued (2023 - 2025)

Sagimet Biosciences' Shares Issued history spans 3 years, with the latest figure at -$25000.0 for Q4 2025.

  • Quarterly Shares Issued changed N/A to -$25000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $274000.0 through Dec 2025, up 140.35% year-over-year, with the annual reading at $275000.0 for FY2025, 141.23% up from the prior year.
  • Shares Issued came in at -$25000.0 for Q4 2025, down from $299000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $299000.0 in Q3 2025 to a low of -$25000.0 in Q4 2025.
  • The 3-year median for Shares Issued is $14000.0 (2024), against an average of $78800.0.